Why the study?
Plasma volume is rarely measured due to complexity and time required, and previous work on indocyanine green dye provided minimal published details or focused on a single aspect of the method.
An optimized protocol for indocyanine green dye enables efficient, less invasive measurement of plasma volume.
Answers are grounded in this paper and cite their sources.
May enable routine plasma volume assessment in heart failure care; leaves open prospective validation before clinical adoption.
Plasma volume (PV) can be an important marker of health status and may affect the interpretation of plasma biomarkers, but is rarely measured due to the complexity and time required. Indocyanine green (ICG) is a water-soluble tricarbocyanine dye with a circulatory half-life of 2-3 min, allowing for quick clearance and repeated use. It is used extensively in medical diagnostic tests including ophthalmologic imaging, liver function, and cardiac output, particularly in critical care. ICG has been validated for measuring PV in humans, however previous work has provided minimal published details or has focused on a single aspect of the method. We aimed to develop a detailed, optimal protocol for the use of ICG to measure PV in women of reproductive age. We combined best practices from other studies and optimized the protocol for efficiency. •This method reduces the time from blood collection to PV determination to ˜2 h and the amount of plasma required to estimate PV to 2.5 mL (1.5 mL before ICG injection and 1.0 mL post-injection).•Participant inconvenience is reduced by inserting an intravenous (IV) catheter in only one arm, not both arms.•Five post-injection plasma samples (2-5 min after ICG bolus) are enough to accurately develop the decay curve for plasma ICG concentration and estimate PV by extrapolation.
No takes yet. Share an insight, caveat, or question.
Aguree et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: